Molecular classification is likely to be of particular value in high‐grade endometrioid carcinomas by picking out the POLE‐mutated (good actors) and the copy‐number high (poor actor) neoplasms.14 This evidence concerns the gene POLE and endometrioid adenocarcinoma.